Background Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) coinfection
has been associated with higher morbidity and mortality and may impact significantly on …

Background Studies on prevalence of epilepsy in Nigeria yielded figures ranging between
3.1 and 37 per 1000, giving one of the widest variations in prevalence of epilepsy world …

Background There is marked variation in the prevalence of epilepsy across Sub-Saharan
Africa (SSA). In order to accurately estimate the clinical and public health impacts of epilepsy …

Purpose We analyzed studies on neurocysticercosis (NCC) and epilepsy across Sub-
Saharan Africa (SSA) to determine the prevalence of NCC in people with epilepsy (PWE) …

Objective To evaluate the prevalence, highlight the variation and determine the trend over
time, of epilepsy treatment gap (ETG) in Sub‐Saharan Africa (SSA). Methods We …

Background: Co-infection of HBV with HIV is associated with significant morbidity and
mortality globally. In spite of increasing reports of HIV/HBV co-morbidities in Nigeria, little or …

Hepatitis B virus (HBV) infection is endemic in sub-Saharan Africa, Nigeria inclusive, and it
is common among HIV/AIDS patients. The aim of this study is to determine the prevalence of …

Background: Hepatitis C affects 5–15% of the 38 million people living with HIV globally.
Africa which has the second highest prevalence of HIV/HCV co-infection following Asia. This …

Background: Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are currently
two important blood-borne human pathogens of major public health concern with high …

ABSTRACT Background: In Nigeria, hepatitis co-infection with HIV is linked with an increase
in morbidity and mortality. Objective: The goal of this study was to investigate the rate of …